A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Clinical trial NCT06603246 · RECRUITING
Trial details
- NCT number
- NCT06603246
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2027-11-15
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.